CLINICAL ROLE -
July 29th 2025
The supplements were also linked to improvements in pain and disease activity markers.
July 24th 2025
There were also no observed differences in retention rates or safety among patients with ankylosing spondylitis.
April 28th 2025
Patients Should Also Have a Diet Rich in Fruits, Oily Fish, and Cereals
April 3rd 2025
Tocilizumab-bavi received FDA approval in September 2023 as the first biosimilar to tocilizumab for the treatment of various adult and pediatric arthritis conditions.
February 24th 2025
Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.
Pregnancy OK with Rheumatoid Arthritis
Read More